How Quan plans to deploy its inaugural $150M healthcare fund
A trio of Chinese biopharma veterans is taking advantage of a growing domestic biotech industry and a wave of innovation-friendly regulatory and policy reforms to establish Quan Capital Management LLC, a global VC that could help healthcare companies on both sides of the Pacific navigate the China market.
Its inaugural fund, Quan Venture Fund L.P., closed at about $150 million in August and will invest in 10 to 15 companies.
While the focus will be on novel therapeutics, the fund will also invest in related areas such as enabling technologies and companion diagnostics.
Together Quan’s three managing directors -- Samantha Du, Marietta Wu and Stella Xu -- have experience in